The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
High‐mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
Open accessAbstract
Summary: A single protein, HMGB 1, directs the triggering of inflammation, innate and adaptive immune responses, and tissue healing after damage. HMGB 1 is the best characterized damage‐associated molecular pattern (DAMP), proteins that are normally inside the cell but are released after cell death, and allow the immune system to distinguish between antigens that are dangerous or not. Notably, cells undergoing severe stress actively secrete HMGB 1 via a dedicated secretion pathway: HMGB 1 is relocated from the nucleus to the cytoplasm and then to secretory lysosomes or directly to the extracellular space. Extracellular HMGB 1 (either released or secreted) triggers inflammation and adaptive immunological responses by switching among multiple oxidation states, which direct the mutually exclusive choices of different binding partners and receptors. Immune cells are first recruited to the damaged tissue and then activated; thereafter, HMGB 1 supports tissue repair and healing, by coordinating the switch of macrophages to a tissue‐healing phenotype, activation and proliferation of stem cells, and neoangiogenesis. Inevitably, HMGB 1 also orchestrates the support of stressed but illegitimate tissues: tumors. Concomitantly, HMGB 1 enhances the immunogenicity of mutated proteins in the tumor (neoantigens), promoting anti‐tumor responses and immunological memory. Tweaking the activities of HMGB 1 in inflammation, immune responses and tissue repair could bring large rewards in the therapy of multiple medical conditions, including cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-citationThe Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Sistigu, A., Yamazaki, T., Vacchelli, E., Chaba, K., Enot, D. P., Adam, J., Vitale, I., Goubar, A., Baracco, E. E., Remédios, C., et al. (2014) · Nature Medicine · doi:10.1038/nm.3708 · Cited by 1,042
Self-citationGardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926
Self-citationMaroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2127 · Cited by 842
Self-citationChiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838
Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786
A New Group of Chromatin‐Associated Proteins with a High Content of Acidic and Basic Amino Acids
Goodwin, G. H., Sanders, C., & Johns, E. W. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb03026.x · Cited by 780
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., & Suffredini, A. F. (2003) · Blood · doi:10.1182/blood-2002-05-1300 · Cited by 737
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720
Self-citationCutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation
Abraham, E., Arcaroli, J., Carmody, A., Wang, H., & Tracey, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2950 · Cited by 692
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676
Self-citationDAMPs from Cell Death to New Life
Vénéreau, E., Ceriotti, C., & Bianchi, M. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00422 · Cited by 666
Self-citationKazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.013 · Cited by 627
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Bald, T., Quast, T., Landsberg, J., Rogava, M., Glodde, N., Lopez-Ramos, D., Kohlmeyer, J., Riesenberg, S., van den Boorn-Konijnenberg, D., Hömig-Hölzel, C., et al. (2014) · Nature · doi:10.1038/nature13111 · Cited by 623
Self-citationTsung, A., Klune, J. R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D. B., Geller, D. A., Rosengart, M. R., & Billiar, T. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070247 · Cited by 620
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Rovere‐Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Müller, S., Iannacone, M., Traversari, C., et al. (2004) · EMBO reports · doi:10.1038/sj.embor.7400205 · Cited by 591
Self-citationRaucci, A., Cugusi, S., Antonelli, A., Barabino, S. M., Monti, L., Bierhaus, A., Reiss, K., Saftig, P., & Bianchi, M. E. (2008) · The FASEB Journal · doi:10.1096/fj.08-109033 · Cited by 555
Self-citationUrbonaviciute, V., Fürnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., Bianchi, M. E., Kirschning, C., Wagner, H., Manfredi, A. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081165 · Cited by 517
Self-citationDumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., & Rovere-Querini, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7506 · Cited by 503
Self-citationRAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages
Kokkola, R., Andersson, Å., Mullins, G., Östberg, T., Treutiger, C. ‐., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., & Harris, H. E. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01534.x · Cited by 496
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S., Dragoi, A.-M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 470
Self-citationExtracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation
Palumbo, R., Sampaolesi, M., De Marchis, F., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G., & Bianchi, M. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200304135 · Cited by 469
Self-citationMessmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., & Chiorazzi, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.307 · Cited by 447
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P. P., Bierhaus, A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2435-08.2008 · Cited by 412
HMGB proteins and gene expression
Agresti, A., & Bianchi, M. E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00023-6 · Cited by 394
Self-citationMD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundbäck, P., Long, W., Valdes-Ferrer, S. I., He, M., Pribis, J. P., Li, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141318 · Cited by 375
Platelet-derived HMGB1 is a critical mediator of thrombosis
Vogel, S., Bodenstein, R., Chen, Q., Feil, S., Feil, R., Rheinlaender, J., Schäffer, T. E., Bohn, E., Frick, J.-S., Borst, O., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81660 · Cited by 370
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Lu, B., Antoine, D. J., Kwan, K., Lundbäck, P., Wähämaa, H., Schierbeck, H., Robinson, M., Van Zoelen, M. A. D., Yang, H., Li, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316925111 · Cited by 366
RAGE: a single receptor fits multiple ligands
Fritz, G. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.008 · Cited by 340
Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice
Stark, K., Philippi, V., Stockhausen, S., Busse, J., Antonelli, A., Miller, M., Schubert, I., Hoseinpour, P., Chandraratne, S., von Brühl, M.-L., et al. (2016) · Blood · doi:10.1182/blood-2016-04-710632 · Cited by 305
Self-citationHigh-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells
Chavakis, E., Hain, A., Vinci, M., Carmona, G., Bianchi, M. E., Vajkoczy, P., Zeiher, A. M., Chavakis, T., & Dimmeler, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257774.55970.f4 · Cited by 298
Self-citationLimana, F., Germani, A., Zacheo, A., Kajstura, J., Di Carlo, A., Borsellino, G., Leoni, O., Palumbo, R., Battistini, L., Rastaldo, R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000186276.06104.04 · Cited by 289
Self-citationYang, H., Rivera, Z., Jube, S., Nasu, M., Bertino, P., Goparaju, C., Franzoso, G., Lotze, M. T., Krausz, T., Pass, H. I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006542107 · Cited by 281
Self-citationDefective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Yamazaki, T., Hannani, D., Poirier-Colame, V, Ladoire, S., Locher, C., Sistigu, A., Prada, N., Adjemian, S., Catani, J. P., Freudenberg, M., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.72 · Cited by 262
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Jube, S., Rivera, Z. S., Bianchi, M. E., Powers, A., Wang, E., Pagano, I., Pass, H. I., Gaudino, G., Carbone, M., & Yang, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3481 · Cited by 255
Self-citationThe secretion of HMGB1 is required for the migration of maturing dendritic cells
Dumitriu, I. E., Bianchi, M. E., Bacci, M., Manfredi, A. A., & Rovere-Querini, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306171 · Cited by 247
Self-citationTamai, K., Yamazaki, T., Chino, T., Ishii, M., Otsuru, S., Kikuchi, Y., Iinuma, S., Saga, K., Nimura, K., Shimbo, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016753108 · Cited by 244
van Beijnum, J. R., Dings, R. P., van der Linden, E., Zwaans, B. M. M., Ramaekers, F. C. S., Mayo, K. H., & Griffioen, A. W. (2006) · Blood · doi:10.1182/blood-2006-02-004291 · Cited by 244
HMGB1 as biomarker and drug target
Venereau, E., De Leo, F., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 240
Self-citationCutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
Mitola, S., Belleri, M., Urbinati, C., Coltrini, D., Sparatore, B., Pedrazzi, M., Melloni, E., & Presta, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.12 · Cited by 229
Parkkinen, J., Raulo, E., Merenmies, J., Nolo, R., Kajander, E. O., Baumann, M., & Rauvala, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36575-5 · Cited by 216
HMGB1 and leukocyte migration during trauma and sterile inflammation
Venereau, E., Schiraldi, M., Uguccioni, M., & Bianchi, M. E. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.10.037 · Cited by 211
Self-citationPawig, L., Klasen, C., Weber, C., Bernhagen, J., & Noels, H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00429 · Cited by 209
Celona, B., Weiner, A., Di Felice, F., Mancuso, F. M., Cesarini, E., Rossi, R. L., Gregory, L., Baban, D., Rossetti, G., Grianti, P., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001086 · Cited by 196
Self-citationTLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells
Mittal, D., Saccheri, F., Vénéreau, E., Pusterla, T., Bianchi, M. E., & Rescigno, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.94 · Cited by 192
Self-citationMolecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1
Hoppe, G., Talcott, K. E., Bhattacharya, S. K., Crabb, J. W., & Sears, J. E. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.07.020 · Cited by 191
Agalave, N. M., Larsson, M., Abdelmoaty, S., Su, J., Baharpoor, A., Lundbäck, P., Palmblad, K., Andersson, U., Harris, H., & Svensson, C. I. (2014) · Pain · doi:10.1016/j.pain.2014.06.007 · Cited by 178
Oh, Y. J., Youn, J. H., Ji, Y., Lee, S. E., Lim, K. J., Choi, J. E., & Shin, J.-S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801873 · Cited by 177
Sessa, L., Gatti, E., Zeni, F., Antonelli, A., Catucci, A., Koch, M., Pompilio, G., Fritz, G., Raucci, A., & Bianchi, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086903 · Cited by 159
Self-citationHigh Mobility Group 1 Protein Is Not Stably Associated with the Chromosomes of Somatic Cells
Falciola, L., Spada, F., Calogero, S., Längst, G., Voit, R., Grummt, I., & Bianchi, M. E. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.19 · Cited by 124
Self-citationNapolitano, A., Antoine, D. J., Pellegrini, L., Baumann, F., Pagano, I., Pastorino, S., Goparaju, C. M. V., Prokrym, K., Canino, C., Pass, H. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1130 · Cited by 118
Ladoire, S., Penault-Llorca, F. M., Senovilla, L., Dalban, C., Enot, D. P., Locher, C., Prada, N., Poirier-Colame, V., Chaba, K., Arnould, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082022 · Cited by 116
Yeast Nhp6A/B and Mammalian Hmgb1 Facilitate the Maintenance of Genome Stability
Giavara, S., Kosmidou, E., Hande, M. P., Bianchi, M. E., Morgan, A., di Fagagna, F. D., & Jackson, S. P. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.065 · Cited by 104
Self-citationMeng, E., Guo, Z., Wang, H., Jin, J., Wang, J., Wang, H., Wu, C., & Wang, L. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0276 · Cited by 103
The evolution of High Mobility Group Box (HMGB) chromatin proteins in multicellular animals
Sessa, L., & Bianchi, M. E. (2006) · Gene · doi:10.1016/j.gene.2006.08.034 · Cited by 95
Self-citationCornelissen, R., Lievense, L. A., Maat, A. P., Hendriks, R. W., Hoogsteden, H. C., Bogers, A. J., Hegmans, J. P., & Aerts, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106742 · Cited by 91
Choi, H. W., Manohar, M., Manosalva, P. M., Tian, M., Moreau, M., & Klessig, D. F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005518 · Cited by 90
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA
Dormoy-Raclet, V., Cammas, A., Celona, B., Lian, X. J., van der Giessen, K., Zivojnovic, M., Brunelli, S., Riuzzi, F., Sorci, G., Wilhelm, B. T., et al. (2013) · Nature Communications · doi:10.1038/ncomms3388 · Cited by 89
Self-citationAspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
Yang, H., Pellegrini, L., Napolitano, A., Giorgi, C., Jube, S., Preti, A., Jennings, C. J., Marchis, F. D., Flores, E. G., LARSON, D. L., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.153 · Cited by 83
Self-citationKew, R. R., Penzo, M., Habiel, D. M., & Marcu, K. B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102454 · Cited by 80
Mesothelioma: recent highlights
Carbone, M., & Yang, H. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.29 · Cited by 79
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
Collins, P. J., McCully, M. L., Martínez‐Muñoz, L., Santiago, C. A., Wheeldon, J., Caucheteux, S. M., Thelen, S., Cecchinato, V., Laufer, J. M., Purvanov, V., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700013r · Cited by 76
Life after death: targeting high mobility group box 1 in emergent cancer therapies.
Guo, Z. S., Liu, Z., Bartlett, D. L., Tang, D., & Lotze, M. T. (2013) · Europe PMC (PubMed Central) · Cited by 72
Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
Weng, H., Deng, Y., Xie, Y., Liu, H., & Gong, F. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-311 · Cited by 72
Lotfi, R., Eisenbacher, J. L., Solgi, G., Fuchs, K., Yildiz, T., Nienhaus, C., Rojewski, M., & Schrezenmeier, H. (2011) · European Journal of Immunology · doi:10.1002/eji.201041324 · Cited by 66
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
Pellegrini, L., Xue, J., LARSON, D. L., Pastorino, S., Jube, S., Forest, K. H., Saad-Jube, Z., Napolitano, A., Pagano, I., Negi, V. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15152 · Cited by 57
Self-citationHow macrophages ring the inflammation alarm
Bianchi, M. E., & Manfredi, A. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324285111 · Cited by 52
Self-citationCottone, L., Capobianco, A., Gualteroni, C., Perrotta, C., Bianchi, M. E., Rovere, P. Q., & Manfredi, A. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29125 · Cited by 49
Self-citationLeukocyte HMGB1 Is Required for Vessel Remodeling in Regenerating Muscles
Campana, L., Santarella, F., Esposito, A., Maugeri, N., Rigamonti, E., Monno, A., Canu, T., Maschio, A. D., Bianchi, M. E., Manfredi, A. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300938 · Cited by 47
Self-citationBraley, A. E., Kwak, T., Jules, J., Harja, E., Landgraf, R., & Hudson, B. I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702399 · Cited by 46
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
Cottone, L., Capobianco, A., Gualteroni, C., Monno, A., Raccagni, I., Valtorta, S., Canu, T., Tomaso, T. D., Lombardo, A., Esposito, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1122860 · Cited by 23
Self-citationDisulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4
Ma, F., Kouzoukas, D. E., Meyer‐Siegler, K. L., Westlund, K. N., Hunt, D. E., & Vera, P. L. (2017) · BMC Physiology · doi:10.1186/s12899-017-0032-9 · Cited by 23
Trisciuoglio, L., & Bianchi, M. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006234 · Cited by 18
Self-citationLi, J., Zhang, Y., Xiang, Z., Xiao, S., Feng, Y. Y., & Yu, Z. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.04.001 · Cited by 18
Cited by
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Li, C., Xu, X., Wei, S., Jiang, P., Xue, L., & Wang, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001341 · Cited by 360
Cavalli, G., Colafrancesco, S., Emmi, G., Imazio, M., Lopalco, G., Maggio, M. C., Sota, J., & Dinarello, C. A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102763 · Cited by 346
Metadata
- Authors
- Bianchi, M. E., Crippa, M. P., Manfredi, A. A., Mezzapelle, R., Rovere Querini, P., & Venereau, E.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2017-10-13
- Volume
- 280
- Issue
- 1
- Pages
- 74-82
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2761593114
- Cited by
- 330
- References
- 88
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.